Malignant Pleural Mesothelioma
📧 Sign up to get email alerts when something new happens for Malignant Pleural Mesothelioma.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-08-21FDA Approved: PEMETREXED — Original Application (Teva Pharmaceuticals, Inc.)
The FDA approved Teva Pharmaceuticals' original application for pemetrexed, a chemotherapy agent indicated for non-small cell lung cancer an…
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM) [Phase 2]
Phase II trial update for Anetumab Ravtansine as second-line treatment in malignant pleural mesothelioma has completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2020-07-09Clinical Trial Update: Efficacy of a Maintenance Treatment With TALAzoparib Following First Line Platinum-based Chemotherapy in Malignant MESOthelioma [Phase 2]
Phase 2 trial evaluating maintenance TALAzoparib after first-line platinum chemotherapy in advanced malignant pleural or peritoneal mesothel…
-
FDA approval · 2020-06-17FDA Approved: PEMFEXY — Supplemental Application (Eagle Pharmaceuticals, Inc.)
The FDA approved a supplemental application for PEMFEXY (pemetrexed) from Eagle Pharmaceuticals, Inc. under NDA 209472.
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM) [Phase 2]
Phase 2 study of amatuximab combined with pemetrexed and cisplatin in unresectable malignant pleural mesothelioma was terminated with result…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-02-18Clinical Trial Update: Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural Mesothelioma [NA]
Clinical trial update on accelerated hypofractionated radiation therapy before surgery for malignant pleural mesothelioma; study is terminat…
-
FDA approval · 2020-02-08FDA Approved: PEMFEXY — Original Application (Eagle Pharmaceuticals, Inc.)
FDA approved PEMFEXY (pemetrexed) from Eagle Pharmaceuticals in an Original Application, adding a pemetrexed injection option.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating pemetrexed disodium with cisplatin, with or without cediranib, in malignant pleural mesothelioma; result…
-
CLINICAL_TRIALS trial_result · 2020-01-23Clinical Trial Update: ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM) [Phase 2]
Phase II study evaluating activity of trabectedin in malignant pleural mesothelioma has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma [Phase 1]
Phase 1 trial evaluating LMB-100 in combination with SEL-110 for mesothelioma has been terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-13Clinical Trial Update: Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma [Phase 1, Phase 2]
Phase 1/2 trial evaluating ganetespib with platinum in malignant pleural mesothelioma has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma [Phase 2]
Phase 2 study of durvalumab in combination with tremelimumab for malignant pleural mesothelioma was terminated, with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed [Phase 3]
Phase 3 trial update for NGR015 in second-line malignant pleural mesothelioma; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma [Phase 2]
Phase 2 clinical trial evaluating pemetrexed disodium and cisplatin followed by surgery with or without radiation therapy for malignant pleu…
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: Evaluation of CRS-207 With Pembrolizumab in Previously Treated Malignant Pleural Mesothelioma (MPM) [Phase 2]
Phase 2 trial evaluating CRS-207 with pembrolizumab in previously treated malignant pleural mesothelioma was terminated.
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma [Phase 2]
Phase 2 trial of NGR-hTNF as a single agent in advanced or metastatic malignant pleural mesothelioma completed.
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced MPM [Phase 2]
Phase II trial evaluating NGR-hTNF vs placebo as maintenance in advanced malignant pleural mesothelioma has completed.
-
CLINICAL_TRIALS trial_result · 2018-09-25Clinical Trial Update: Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR) [Phase 2]
Phase 2 trial evaluating TTFields (150 kHz) with pemetrexed and platinum in malignant pleural mesothelioma has completed.
-
CLINICAL_TRIALS research · 2018-07-23Clinical Trial Update: The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural Mesothelioma [NA]
This update summarizes a completed clinical trial comparing the ISET (Isolation by Size of Epithelial Tumor Cells) and CellSearch methods in…
-
CLINICAL_TRIALS withdrawal · 2018-07-03Clinical Trial Update: Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body [NA]
A Wake Forest University Health Sciences-sponsored clinical trial evaluating cryotherapy for metastatic lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-05-14Clinical Trial Update: A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy [Phase 1]
The trial investigating maintenance multipeptide vaccine S-588210 in unresectable malignant pleural mesothelioma after first-line chemothera…
-
FDA approval · 2018-04-17FDA Approved: ALIMTA — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for ALIMTA (pemetrexed disodium) from Eli Lilly and Company.
-
CLINICAL_TRIALS research · 2018-02-23Clinical Trial Update: Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma
A clinical trial investigating how the expression of CD74 and VEGF affects treatment outcomes in patients with malignant pleural mesotheliom…
-
CLINICAL_TRIALS trial_result · 2018-01-29Clinical Trial Update: PIT: Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma [Phase 3]
Phase 3 trial update for prophylactic irradiation of tracts in malignant pleural mesothelioma has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-09-14Clinical Trial Update: Nivolumab in Patients With Recurrent Malignant Mesothelioma [Phase 2]
Phase 2 clinical trial update for nivolumab in recurrent malignant pleural mesothelioma.